Synergy Pharmaceuticals (SGYP) Closes Plecanatide Phase 2b Enrollment
Tweet Send to a Friend
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced it has closed patient enrollment in its plecanatide phase 2b clinical trial in irritable ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE